✦ LIBER ✦

Clinical predictors of bevacizumab-associated gastrointestinal perforation

✍ Scribed by Janos L. Tanyi; Georgia McCann; Andrea R. Hagemann; George Coukos; Stephen C. Rubin; John B. Liao; Christina S. Chu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab-associated gastrointestinal

✍ Ian Chau; David Cunningham 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 82 KB

Gastrointestinal perforation in metastat

✍ D. Collins; P.F. Ridgway; D.C. Winter; D. Fennelly; D. Evoy 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Incidence and management of bevacizumab-

✍ John P. Diaz; William P. Tew; Oliver Zivanovic; Jason Konner; Paul J. Sabbatini; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Incidence and Management of Gastrointest

✍ Taher Abu-Hejleh, James J. Mezhir, Michael J. Goodheart, Thorvardur R. Halfdanar 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 174 KB

Gastrointestinal perforation associated

✍ Fairooz F. Kabbinavar; Patrick J. Flynn; Mark Kozloff; Mark A. Ashby; Amy Sing; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Risk of gastrointestinal perforation in

✍ Sanjaykumar Hapani; David Chu; Shenhong Wu 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 171 KB